Misonix Inc. (MSON)
-NasdaqGM | Prev Close: | 5.55 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 8.50 |
|---|
| Beta: | 0 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 2.03 - 9.13 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 16,564 |
|---|
| Market Cap: | 39.36M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.11 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- MISONIX INC FinancialsEDGAR Online Financials(Fri, May 17)
- MISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Thu, May 16)
- Misonix Appoints Scott Ludecker Vice President of Global Sales and MarketingPR Newswire(Mon, May 13)
- Misonix Appoints Stavros Vizirgianakis to Board of DirectorsPR Newswire(Fri, May 10)
- MISONIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial CondiEDGAR Online(Fri, May 10)
- MISONIX INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- Misonix Earnings Call scheduled for 4:30 pm ET todayCCBN(Thu, May 9)
- Misonix Reports Nine Months Fiscal 2013 Financial ResultsPR Newswire(Thu, May 9)
- Q3 2013 Misonix Earnings Release - After Market CloseCCBN(Thu, May 9)
- Misonix, Inc. To Report Financial Results For The Third Quarter Fiscal 2013 On Thursday, May 9, 2013PR Newswire(Fri, May 3)
- Misonix Announces New Distribution Agreement For DenmarkPR Newswire(Tue, Apr 2)
- Misonix BoneScalpel™ Subject of New Clinical Paper Focused on Spine SurgeryPR Newswire(Tue, Mar 26)
- Sears CEO Buys $54 Million in Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed, Mar 6)
- Misonix BoneScalpel™ Highlighted In New Clinical Paper Aimed At Face And Jaw SurgeryPR Newswire(Tue, Mar 5)
- Trade group identifies medical device makers passing on U.S. taxat Reuters(Thu, Feb 28)
Key Statistics
| Forward P/E (1 yr): | 92.50 |
|---|
| P/S (ttm): | 2.40 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | -0.16 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.00 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Misonix, Inc. designs, manufactures, develops, and markets minimally invasive ultrasonic medical device products. The company offers BoneScalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; So...
View More 
0.08%